started · updated
Obesity injectable treatments require muscle preservation strategies
Medical professionals are highlighting the importance of specialized strategies when using injectable medications for obesity treatment. While these drugs effectively control appetite and promote weight loss, experts warn that the primary goal should be reducing body fat while preserving muscle mass.
To prevent sarcopenia (muscle loss) and reduced bone density, specialists recommend prioritizing high protein intake and regular resistance training, ideally at least three times per week. Because these medications can delay gastric emptying and reduce appetite, patients may struggle to meet essential requirements for proteins, vitamins, minerals, and fluids.
Potential side effects include nausea, constipation, dizziness, and hair loss. Furthermore, experts warn that these treatments can interfere with the absorption of oral contraceptives. The medication is generally contraindicated for individuals with a history of medullary thyroid cancer, gallbladder issues, or kidney stones.
Entities
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] The medications may alter the absorption of oral contraceptives. www.telefuturo.com.py
- [○ 1 SOURCE] The treatment is contraindicated for individuals with a history of medullary thyroid cancer, gallbladder issues, or kidney stones. www.telefuturo.com.py
- [○ 1 SOURCE] Resistance training is recommended at least three times per week to preserve muscle mass. visionrdn.com
- [○ 1 SOURCE] Injectable obesity medications are medical treatments rather than simple solutions. www.telefuturo.com.py
- [○ 1 SOURCE] Serious side effects can include sarcopenia and reduced bone density. www.telefuturo.com.py
- [● 2 SOURCES] Rapid weight loss without adequate nutrition and exercise can lead to loss of lean muscle mass. visionrdn.com · jcmagazine.com
- [○ 1 SOURCE] GLP-1 pathway medications can reduce appetite and delay gastric emptying. visionrdn.com